The purpose of this research is to investigate the efficacy of transplanting screened donor fecal material in treating patients with recurrent Clostridium difficile infection. Participants with refractory Clostridium difficile infection will be given healthy donor stool administered by colonoscopy or enema and their response will be evaluated by symptom questionnaire and stool testing for Clostridium difficile at 4 weeks after the treatment.
Study Type
OBSERVATIONAL
Enrollment
37
Participants with refractory Clostridium difficile infection will be given healthy donor stool administered by colonoscopy or enema.
University of California, Irvine Medical Center
Orange, California, United States
The recurrence rate of Clostridium difficile 4 weeks after FMT.
Time frame: Four weeks
Clinical symptoms from before fecal microbiota transplant (FMT) to 4 weeks after FMT.
Time frame: Four weeks
Satisfaction with the FMT procedure. ( satisfaction questionnaire )
Subjects will complete a satisfaction questionnaire following the FMT procedure.
Time frame: Up to 24 weeks
Quality of life before and 4 weeks after FMT.
Subjects will complete a quality of life questionnaire before and 4 weeks after FMT.
Time frame: Four weeks
Alternate treatments needed for Clostridium difficile before and after FMT.
Subjects medication and treatment history for Clostridium difficile before and after FMT will be collected.
Time frame: Up to 24 weeks
The rate of adverse events that may be related to FMT.
Time frame: Up to 24 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.